Urmi Dhagat

Urmi Dhagat

Auto-generated profile, based on publicly available information

Urmi Dhagat

Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2012 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
SBSophie E. Broughton
Sophie E. Broughton
UDUrmi Dhagat
Urmi Dhagat
THTimothy R. Hercus
Timothy R. Hercus
TNTracy L. Nero
Tracy L. Nero
MGMichele A. Grimbaldeston
Michele A. Grimbaldeston
MPMichael Parker
Michael Parker

1 June 2013 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
THTimothy R. Hercus
Timothy R. Hercus
UDUrmi Dhagat
Urmi Dhagat
WKWinnie L.T. Kan
Winnie L.T. Kan
SBSophie E. Broughton
Sophie E. Broughton
TNTracy L. Nero
Tracy L. Nero
ALAngel F. Lopez
Angel F. Lopez

1 August 2015 in Cytokine
Verified
Journal Article
Closed access
SBSophie E. Broughton
Sophie E. Broughton
TNTracy L. Nero
Tracy L. Nero
UDUrmi Dhagat
Urmi Dhagat
WKWinnie L. Kan
Winnie L. Kan
THTimothy R. Hercus
Timothy R. Hercus
MPMichael Parker
Michael Parker

1 July 2014 in Cell Reports
Verified
Journal Article
Open access
SBSophie E. Broughton
Sophie E. Broughton
THTimothy R. Hercus
Timothy R. Hercus
MHMatthew P. Hardy
Matthew P. Hardy
BMBarbara J. McClure
Barbara J. McClure
TNTracy L. Nero
Tracy L. Nero
ALAngel F. Lopez
Angel F. Lopez
Interleukin-3 (IL-3) is an activated T cell product that bridges innate and adaptive immunity and contributes to several immunopathologies. Here, we report the crystal structure of the IL-3 receptor α chain (IL3Rα) in complex with the anti-leukemia antibody CSL362 that reveals the N-terminal domain (NTD), a domain also present in the granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-5, and IL-13 receptors, adopting unique "open" and classical "closed" conformations. Although extensive mutational analyses of the NTD epitope of CSL362 show minor overlap with the IL-3 binding site, CSL362 only inhibits IL-3 binding to the closed conformation, indicating alternative mechanisms for blocking IL-3 signaling. Significantly, whereas "open-like" IL3Rα mutants can simultaneously bind IL-3 and CSL362, CSL362 still prevents the assembly of a higher-order IL-3 receptor-signaling complex. The discovery of open forms of cytokine receptors provides the framework for development of potent antibodies that can achieve a "double hit" cytokine receptor blockade.

1 August 2016 in Structure
Verified
Journal Article
Closed access
SBSophie E. Broughton
Sophie E. Broughton
THTimothy R. Hercus
Timothy R. Hercus
TNTracy L. Nero
Tracy L. Nero
MDMara Dottore
Mara Dottore
BMBarbara J. McClure
Barbara J. McClure
MPMichael Parker
Michael Parker

17 July 2017 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
THTimothy R. Hercus
Timothy R. Hercus
WKWinnie L. T. Kan
Winnie L. T. Kan
SBSophie E. Broughton
Sophie E. Broughton
DTDenis Tvorogov
Denis Tvorogov
HRHayley S. Ramshaw
Hayley S. Ramshaw
ALAngel F. Lopez
Angel F. Lopez
The β common ([βc]/CD131) family of cytokines comprises granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3, and IL-5, all of which use βc as their key signaling receptor subunit. This is a prototypic signaling subunit-sharing cytokine family that has unveiled many biological paradigms and structural principles applicable to the IL-2, IL-4, and IL-6 receptor families, all of which also share one or more signaling subunits. Originally identified for their functions in the hematopoietic system, the βc cytokines are now known to be truly pleiotropic, impacting on multiple cell types, organs, and biological systems, and thereby controlling the balance between health and disease. This review will focus on the emerging biological roles for the βc cytokines, our progress toward understanding the mechanisms of receptor assembly and signaling, and the application of this knowledge to develop exciting new therapeutic approaches against human disease.